Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease aspergillosis
Comorbidity C0376545|hematologic malignancies
Sentences 7
PubMedID- 19801584 Contribution of galactomannan antigen detection in bal to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
PubMedID- 21281234 Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies.
PubMedID- 20502511 Current clinical evidence for the use of aerosolized delivery is limited to amphotericin b products for prophylaxis against invasive pulmonary aspergillosis in patients with hematologic malignancies or lung transplantation.
PubMedID- 21087680 Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
PubMedID- 25018923 Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin b alone or in combination with caspofungin.
PubMedID- 22712456 Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies.
PubMedID- 21791468 Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009.

Page: 1